Cargando…

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma

OBJECTIVE: Recently, single nucleotide polymorphisms (SNPs) associated with esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) were identified; rs10419226 (CRTC1), rs11789015 (BARX1), rs2687201 (FOXP1), rs2178146 (FOXF1), rs3111601 (FOXF1), and rs9936833 (FOXF1). These findings indica...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Nistelrooij, Anna M. J., van der Korput, Hetty A. G. M., Broer, Linda, van Marion, Ronald, van Berge Henegouwen, Mark I., van Noesel, Carel J., Biermann, Katharina, Spaander, Manon C. W., Tilanus, Hugo W., van Lanschot, J. Jan B., Hofman, Albert, Uitterlinden, André G., Wijnhoven, Bas P. L., Dinjens, Winand N. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453126/ https://www.ncbi.nlm.nih.gov/pubmed/26085818 http://dx.doi.org/10.4103/1477-3163.157441

Ejemplares similares

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
por: van Nistelrooij, Anna M. J., et al.
Publicado: (2017)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma
por: van Nistelrooij, A. M. J., et al.
Publicado: (2017)

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
por: Boonstra, Jurjen J, et al.
Publicado: (2011)

A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer
por: Alves, Inês Teles, et al.
Publicado: (2016)

Delay in Diagnostic Workup and Treatment of Esophageal Cancer
por: Grotenhuis, Brechtje A., et al.
Publicado: (2009)

Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus
por: Boonstra, Jurjen J., et al.
Publicado: (2010)

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol
por: Noordman, Bo Jan, et al.
Publicado: (2015)

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
por: van Heijl, M, et al.
Publicado: (2008)

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017)

Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
por: Wijnhoven, Bas P. L., et al.
Publicado: (2009)

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
por: Wijnhoven, B P L, et al.
Publicado: (1999)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer
por: Grotenhuis, B. A., et al.
Publicado: (2010)

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission
por: Grotenhuis, B.A., et al.
Publicado: (2009)

Unexplained mismatch repair deficiency: Case closed
por: Eikenboom, Ellis L., et al.
Publicado: (2022)

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer
por: Talsma, Koen, et al.
Publicado: (2012)

Activation of the adipocyte CREB/CRTC pathway in obesity
por: Yoon, Young-Sil, et al.
Publicado: (2021)

Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
por: van Heijl, Mark, et al.
Publicado: (2009)

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
por: Suzuki, Lucia, et al.
Publicado: (2019)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
por: van der Wilk, B. J., et al.
Publicado: (2020)

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers
por: Eikenboom, Ellis L., et al.
Publicado: (2021)

A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
por: Van Lier, Margot GF, et al.
Publicado: (2010)

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116
por: Wijnhoven, B P L, et al.
Publicado: (2000)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Unique case of esophageal rupture after a fall from height
por: van Heijl, Mark, et al.
Publicado: (2009)

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression
por: Koppert, L B, et al.
Publicado: (2004)

A single blinded randomized controlled trial comparing semi‐mechanical with hand‐sewn cervical anastomosis after esophagectomy for cancer (SHARE‐study)
por: Nederlof, Nina, et al.
Publicado: (2020)

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma
por: ten Kate, F. J. C., et al.
Publicado: (2017)

Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis
por: Spoor, Jonathan, et al.
Publicado: (2021)

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2
por: van der Zijden, Charlène J., et al.
Publicado: (2023)

Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation
por: Gasi, Delila, et al.
Publicado: (2011)

A Propensity Score-Matched Cohort Study to Evaluate the Association of Lymph Node Retrieval with Long-Term Overall Survival in Patients with Esophageal Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2020)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study
por: Markar, S. R., et al.
Publicado: (2017)

Immunohistochemical Localization of Barx2 in the Developing Fetal Mouse Submandibular Glands
por: Naka, Takahiro, et al.
Publicado: (2009)

Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years
por: Buis, Christien C.M, et al.
Publicado: (2010)

Mucoepidermoid carcinoma of the head and neck: CRTC1/3 MAML 2 translocation and its prognosticators
por: van Weert, Stijn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1p8vibtngeqoee4mh90020337v